PDPP, a polyvalent-directed peptide polymer, recognized breast cancer stem cells using combinational peptides P6 and P7, displaying a higher affinity and inhibition potential against the CD44 biomarker in breast CSCs [154]. Here, CD44 is linked to breast cancer.